The meeting convened researchers, industry leaders, nonprofit organizations, and lived experience experts to discuss ways to enhance the inclusion of women and girls with bleeding disorders in research.

This publication is an excellent resource for both affected women and girls, caregivers, and health care providers who can utilize it to help inform shared decision making with their patients.

The pre-clinical stage biotech focused on RNA and nanomedicine.

The three new documents approved by NBDF's Medical and Scientific Advisory Council include important recommendations on the off-label use of emicizumab in acquired hemophilia, the use of anti-tissue factor pathway inhibitors in hemophilia, and the role of HTC social workers.

The new comprehensive and holistic guidelines offer physicians and other prescribers access to the latest evidence-based clinical guidance and help patients make more informed decisions about gene therapy.

Patients will continue to have access to ROCTAVIAN during the licensing transition.

NFRC's Resource Roundup is a monthly communication designed to connect the bleeding disorders community with practical and readily accessible resources.

Inside the expert committee guiding biotech investments toward cures for inheritable blood and bleeding disorders.

The Irish Haemophilia Society is hosting a series of clinical webinars on key topics developed for healthcare providers practicing in the global bleeding disorders community.